Looking to publish in Neurodegenerative Disease Management? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowNeurodegenerative Disease Management is a MEDLINE-indexed, peer-reviewed journal focused on treatment strategies, emerging research, and multidisciplinary management of neurodegenerative diseases. It covers topics including disease mechanisms, epidemiology, diagnosis, biomarkers, therapeutic options, cognitive impairment and dementia, new treatments such as cell and gene therapy, pharmacoeconomics, real-world evidence, quality of life, and palliative care. Articles are peer reviewed by three independent referees on a double-blind basis, and the journal welcomes unsolicited article proposals.
Looking to publish in Neurodegenerative Disease Management? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Neurodegenerative Disease Management accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Original Research
Drug Evaluation Articles
Recent Publications
Diagnosis and management of frontotemporal dementia: a narrative review
Valentina Cenacchi, Tiziana Lombardo, Federica Palacino, Tatiana Cattaruzza, Paolo Manganotti, Alberto Benussi
Association between influenza infection and subsequent Parkinson’s disease diagnosis: a systematic review and meta-analysis
Alice Halim, Shin Jie Yong, Anood A. Alenezy, Maha A. Aljumaa, Zainab H. Almansour, Hayam A. Alrasheed, Ali Hazazi, Nawal A. Al Kaabi, Ali A. Zaidan, Mashahed Y. Almoutawa, Nada N. Alshehri, Jumana M. Al-Jishi, Mohammed S. Almogbel, Rana Abdulrahim Ali Alaeq, Ali A. Rabaan
Supporting gastrostomy decision-making in motor neurone disease (MND): an Australian survey of healthcare professionals’ beliefs, practices, and needs
Sarah El-Wahsh, Elise Bogart, Susannah Bonnor, Shadi El-Wahsh, Marnie Graco, Anne Hogden, Camille Paynter, Veena Raykar, Monique Signorelli, Emma Thomson, Steve Vucic, Sean White
Association of self-efficacy and self-management with multiple sclerosis patients’ quality of life: a descriptive-analytical study
Mahnaz Atapour, Farzaneh Maghaminejad, Shahrzad Ghiyasvandian, Mitra Rahimzadeh
Bright light therapy for depression and excessive daytime sleepiness in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials with dose-response meta-regression
Mark Messak, Ahmed Abdelmageed, Youssef A. Khattab, Youssef Mandour, Omar Shaker, Ahmed Negida
Frequently asked questions
How long does it take to publish?
Accelerated Publication offers a final decision in as little as 3 weeks or 9 weeks from submission. Online publication usually occurs 1-2 weeks or 2-3 weeks after acceptance. First proofs are provided within 5 working days.
Reformat to Neurodegenerative Disease Management using Livewrite PremiumIs a cover letter required?
Journals may require authors, prior to acceptance, to sign a letter certifying that legal and ethical requirements for humane animal treatment have been met.
Reformat to Neurodegenerative Disease Management using Livewrite PremiumWhat are the publication costs?
Subscription journal. Individual subscription prices are USD 2,491.00 for online only and USD 3,642.00 for print and online.
Reformat to Neurodegenerative Disease Management using Livewrite Premium